ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 18.35 Delayed Data As of Mar 23 |  -0.15 / -0.81%Today’s Change | 12.24 Today|||52-Week Range 28.06 | +15.26% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Brege Laura A Director |  Sale | 1/12/2023 | 12,500 | $18.25 | $228.1K | -0.11% |
Brege Laura A Director |  Buy | 1/12/2023 | 12,500 | $17.01 | $212.6K | -0.11% |
Davis Stephen R Chief Executive Officer | Sale | 5/02/2022 | 5,483 | $18.18 | $99.7K | -6.24% |
Baker Bros Advisors Lp Director | Buy | 1/12/2023 | 15,000 | $5.22 | $78.3K | -0.11% |
Baker Bros Advisors Lp Director | Buy | 1/12/2023 | 15,000 | $5.22 | $78.3K | -0.11% |
Davis Stephen R Chief Executive Officer | Sale | 2/24/2023 | 3,851 | $18.78 | $72.3K | -3.17% |
Davis Stephen R Chief Executive Officer | Sale | 1/09/2023 | 3,904 | $17.13 | $66.9K | +8.66% |
Stankovic Srdjan R President | Sale | 5/02/2022 | 2,865 | $18.18 | $52.1K | -6.24% |
Davis Stephen R Chief Executive Officer | Sale | 10/15/2022 | 2,804 | $15.81 | $44.3K | +14.79% |
Stankovic Srdjan R President | Sale | 11/21/2022 | 1,847 | $15.07 | $27.8K | +23.95% |
Page of 4